TY - BOOK AU - Koch-Institut, R. PY - 2013 DA - 2013// TI - Krebs in Deutschland | ID - Koch-Institut2013 ER - TY - JOUR AU - Dühmke, E. AU - Franklin, J. AU - Pfreundschuh, M. PY - 2001 DA - 2001// TI - Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.11.2905 DO - 10.1200/JCO.2001.19.11.2905 ID - Dühmke2001 ER - TY - JOUR AU - Sieber, M. AU - Tesch, H. AU - Pfistner, B. PY - 2004 DA - 2004// TI - Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's lymphoma study group HD6 trial JO - Ann Oncol VL - 15 UR - https://doi.org/10.1093/annonc/mdh046 DO - 10.1093/annonc/mdh046 ID - Sieber2004 ER - TY - JOUR AU - Sieber, M. AU - Tesch, H. AU - Pfistner, B. PY - 2002 DA - 2002// TI - Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's lymphoma study group trial HD5 JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.20.2.476 DO - 10.1200/JCO.2002.20.2.476 ID - Sieber2002 ER - TY - JOUR AU - Engert, A. AU - Franklin, J. AU - Eich, H. T. PY - 2007 DA - 2007// TI - Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.07.0482 DO - 10.1200/JCO.2006.07.0482 ID - Engert2007 ER - TY - JOUR AU - Engert, A. AU - Schiller, P. AU - Josting, A. PY - 2003 DA - 2003// TI - Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's lymphoma study group JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.03.023 DO - 10.1200/JCO.2003.03.023 ID - Engert2003 ER - TY - JOUR AU - Diehl, V. AU - Franklin, J. AU - Pfreundschuh, M. PY - 2003 DA - 2003// TI - Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa022473 DO - 10.1056/NEJMoa022473 ID - Diehl2003 ER - TY - JOUR AU - Eich, H. T. AU - Diehl, V. AU - Görgen, H. PY - 2010 DA - 2010// TI - Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin study group HD11 trial JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.29.8018 DO - 10.1200/JCO.2010.29.8018 ID - Eich2010 ER - TY - JOUR AU - Engert, A. AU - Plütschow, A. AU - Eich, H. T. PY - 2010 DA - 2010// TI - Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1000067 DO - 10.1056/NEJMoa1000067 ID - Engert2010 ER - TY - JOUR AU - Borchmann, P. AU - Haverkamp, H. AU - Diehl, V. PY - 2011 DA - 2011// TI - Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin study group JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.9549 DO - 10.1200/JCO.2010.33.9549 ID - Borchmann2011 ER - TY - JOUR AU - Behringer, K. AU - Goergen, H. AU - Hitz, F. PY - 2015 DA - 2015// TI - Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61469-0 DO - 10.1016/S0140-6736(14)61469-0 ID - Behringer2015 ER - TY - JOUR AU - Tresckow, B. AU - Plütschow, A. AU - Fuchs, M. PY - 2012 DA - 2012// TI - Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin study group HD14 trial JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.38.5807 DO - 10.1200/JCO.2011.38.5807 ID - Tresckow2012 ER - TY - STD TI - Engert A. HD17 for Intermediate Stage Hodgkin Lymphoma. https://clinicaltrials.gov/ct2/show/NCT01356680. UR - https://clinicaltrials.gov/ct2/show/NCT01356680 ID - ref13 ER - TY - STD TI - Engert A. HD16 for Early Stage Hodgkin Lymphoma (HD16). NCT00736320. https://clinicaltrials.gov/ct2/show/NCT00736320. UR - https://clinicaltrials.gov/ct2/show/NCT00736320 ID - ref14 ER - TY - JOUR AU - Schellong, G. AU - Hörnig-Franz, I. AU - Rath, B. PY - 1994 DA - 1994// TI - Reduzierung der Strahlendosen auf 20-30 Gy im Rahmen einer kombinierten Chemo−/Radiotherapie beim Morbus Hodgkin im Kindesalter. Ein Bericht der kooperativen Therapiestudie DAL-HD-87 JO - Klin Padiatr VL - 206 UR - https://doi.org/10.1055/s-2008-1046611 DO - 10.1055/s-2008-1046611 ID - Schellong1994 ER - TY - JOUR AU - Schellong, G. AU - Pötter, R. AU - Brämswig, J. PY - 1999 DA - 1999// TI - High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian pediatric Hodgkin's disease study group JO - J Clin Oncol VL - 17 UR - https://doi.org/10.1200/JCO.1999.17.12.3736 DO - 10.1200/JCO.1999.17.12.3736 ID - Schellong1999 ER - TY - JOUR AU - Schellong, G. AU - Brämswig, J. AU - Ludwig, R. PY - 1986 DA - 1986// TI - Kombinierte Behandlungsstrategie bei über 200 Kindern mit Morbus Hodgkin: Abgestufte Chemotherapie, Involved-Field-Bestrahlung mit erniedrigten Dosen und selektive Splenektomie. Ein Bericht der kooperativen Therapiestudie DAL-HD-82 JO - Klin Padiatr VL - 198 UR - https://doi.org/10.1055/s-2008-1026870 DO - 10.1055/s-2008-1026870 ID - Schellong1986 ER - TY - JOUR AU - Schellong, G. AU - Hörnig, I. AU - Brämswig, J. PY - 1988 DA - 1988// TI - Zur Bedeutung des procarbazins in der Chemo therapie des Morbus Hodgkin--Ein Bericht der Kooperativen Therapiestudie DAL-HD-85 JO - Klin Padiatr VL - 200 UR - https://doi.org/10.1055/s-2008-1033710 DO - 10.1055/s-2008-1033710 ID - Schellong1988 ER - TY - JOUR AU - Schellong, G. PY - 1996 DA - 1996// TI - 11 treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric study group JO - Baillière's Clin Haematol VL - 9 UR - https://doi.org/10.1016/S0950-3536(96)80030-8 DO - 10.1016/S0950-3536(96)80030-8 ID - Schellong1996 ER - TY - JOUR AU - Mauz-Körholz, C. AU - Hasenclever, D. AU - Dörffel, W. PY - 2010 DA - 2010// TI - Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.26.9381 DO - 10.1200/JCO.2009.26.9381 ID - Mauz-Körholz2010 ER - TY - STD TI - Körholz D. First international inter-group study for classical Hodgkin’s lymphoma in children and adolescents - EuroNet-PHL-C1 -. EuroNet-Paediatric Hodgkin’s Lymphoma Group. ID - ref21 ER - TY - JOUR AU - Nimwegen, F. A. AU - Schaapveld, M. AU - Janus, C. P. M. PY - 2015 DA - 2015// TI - Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk JO - JAMA Intern Med VL - 175 UR - https://doi.org/10.1001/jamainternmed.2015.1180 DO - 10.1001/jamainternmed.2015.1180 ID - Nimwegen2015 ER - TY - JOUR AU - Schellong, G. AU - Riepenhausen, M. AU - Bruch, C. PY - 2010 DA - 2010// TI - Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies JO - Pediatr Blood Cancer VL - 55 UR - https://doi.org/10.1002/pbc.22664 DO - 10.1002/pbc.22664 ID - Schellong2010 ER - TY - JOUR AU - Bhatia, S. AU - Robison, L. L. AU - Oberlin, O. PY - 1996 DA - 1996// TI - Breast cancer and other second neoplasms after childhood Hodgkin's disease JO - N Engl J Med VL - 334 UR - https://doi.org/10.1056/NEJM199603213341201 DO - 10.1056/NEJM199603213341201 ID - Bhatia1996 ER - TY - JOUR AU - Schaapveld, M. AU - Aleman, B. M. P. AU - Eggermond, A. M. PY - 2015 DA - 2015// TI - Second Cancer risk up to 40 years after treatment for Hodgkin's lymphoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1505949 DO - 10.1056/NEJMoa1505949 ID - Schaapveld2015 ER - TY - JOUR AU - Travis, L. B. AU - Hill, D. A. AU - Dores, G. M. PY - 2003 DA - 2003// TI - Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.4.465 DO - 10.1001/jama.290.4.465 ID - Travis2003 ER - TY - JOUR AU - Travis, L. B. PY - 2002 DA - 2002// TI - Lung Cancer following chemotherapy and radiotherapy for Hodgkin's disease JO - Cancer Spectr Knowl Environ VL - 94 UR - https://doi.org/10.1093/jnci/94.3.182 DO - 10.1093/jnci/94.3.182 ID - Travis2002 ER - TY - JOUR AU - Halperin, E. C. AU - Greenberg, M. S. AU - Suit, H. D. PY - 1984 DA - 1984// TI - Sarcoma of bone and soft tissue following treatment of Hodgkin's disease JO - Cancer VL - 53 UR - https://doi.org/3.0.CO;2-F DO - 3.0.CO;2-F ID - Halperin1984 ER - TY - JOUR AU - Rajaraman, P. AU - Stovall, M. PY - 2012 DA - 2012// TI - Risk Factors Associated With Secondary Sarcomas in Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study JO - Int J Radiat Oncol *Biol*Phys VL - 84 UR - https://doi.org/10.1016/j.ijrobp.2011.11.022 DO - 10.1016/j.ijrobp.2011.11.022 ID - Rajaraman2012 ER - TY - JOUR AU - Whitton, J. AU - Stovall, M. PY - 2007 DA - 2007// TI - Secondary sarcomas in childhood Cancer survivors: a report from the childhood Cancer survivor study JO - J Natl Cancer Inst VL - 99 UR - https://doi.org/10.1093/jnci/djk052 DO - 10.1093/jnci/djk052 ID - Whitton2007 ER - TY - JOUR AU - Bhatia, S. AU - Yasui, Y. AU - Robison, L. L. PY - 2003 DA - 2003// TI - High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the late effects study group JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.11.059 DO - 10.1200/JCO.2003.11.059 ID - Bhatia2003 ER - TY - JOUR AU - Sigurdson, A. J. AU - Ronckers, C. M. AU - Mertens, A. C. PY - 2005 DA - 2005// TI - Primary thyroid cancer after a first tumour in childhood (the childhood Cancer survivor study): a nested case-control study JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)66695-0 DO - 10.1016/S0140-6736(05)66695-0 ID - Sigurdson2005 ER - TY - JOUR AU - Sklar, C. AU - Whitton, J. AU - Mertens, A. PY - 2000 DA - 2000// TI - Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the childhood Cancer survivor study JO - J Clin Endocrinol Metab VL - 85 UR - https://doi.org/10.1210/jcem.85.9.6808 DO - 10.1210/jcem.85.9.6808 ID - Sklar2000 ER - TY - JOUR AU - Bhakta, N. AU - Liu, Q. AU - Yeo, F. PY - 2016 DA - 2016// TI - Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude lifetime cohort study JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30215-7 DO - 10.1016/S1470-2045(16)30215-7 ID - Bhakta2016 ER - TY - JOUR AU - Filippi, A. R. AU - Ragona, R. AU - Piva, C. PY - 2015 DA - 2015// TI - Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk JO - Int J Radiat Oncol Biol Phys VL - 92 UR - https://doi.org/10.1016/j.ijrobp.2015.02.030 DO - 10.1016/j.ijrobp.2015.02.030 ID - Filippi2015 ER - TY - JOUR AU - Specht, L. AU - Yahalom, J. PY - 2015 DA - 2015// TI - The concept and evolution of involved site radiation therapy for lymphoma JO - Int J Clin Oncol VL - 20 UR - https://doi.org/10.1007/s10147-015-0863-y DO - 10.1007/s10147-015-0863-y ID - Specht2015 ER - TY - JOUR AU - Hoppe, B. S. AU - Flampouri, S. AU - Su, Z. PY - 2012 DA - 2012// TI - Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma JO - Int J Radiat Oncol Biol Phys VL - 84 UR - https://doi.org/10.1016/j.ijrobp.2011.12.034 DO - 10.1016/j.ijrobp.2011.12.034 ID - Hoppe2012 ER - TY - JOUR AU - Hoppe, B. S. AU - Flampouri, S. AU - Su, Z. PY - 2012 DA - 2012// TI - Consolidative involved-node proton therapy for stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a phase II study JO - Int J Radiat Oncol Biol Phys VL - 83 UR - https://doi.org/10.1016/j.ijrobp.2011.06.1959 DO - 10.1016/j.ijrobp.2011.06.1959 ID - Hoppe2012 ER - TY - JOUR AU - Yahalom, J. AU - Illidge, T. AU - Specht, L. PY - 2015 DA - 2015// TI - Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the international lymphoma radiation oncology group JO - Int J Radiat Oncol Biol Phys VL - 92 UR - https://doi.org/10.1016/j.ijrobp.2015.01.009 DO - 10.1016/j.ijrobp.2015.01.009 ID - Yahalom2015 ER - TY - JOUR AU - Hoppe, B. S. AU - Hill-Kayser, C. E. AU - Tseng, Y. D. PY - 2017 DA - 2017// TI - Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx287 DO - 10.1093/annonc/mdx287 ID - Hoppe2017 ER - TY - JOUR AU - Hoppe, B. S. AU - Tsai, H. AU - Larson, G. PY - 2016 DA - 2016// TI - Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry JO - Acta Oncol (Stockholm, Sweden) VL - 55 UR - https://doi.org/10.1080/0284186X.2016.1197422 DO - 10.1080/0284186X.2016.1197422 ID - Hoppe2016 ER - TY - STD TI - Everett AS, Hoppe BS, Louis D, et al. Comparison of techniques for involved-site radiation therapy in patients with lower mediastinal lymphoma. Pract Radiat Oncol. 2019. https://doi.org/10.1016/j.prro.2019.05.009. ID - ref42 ER - TY - JOUR AU - Ntentas, G. AU - Dedeckova, K. AU - Andrlik, M. PY - 2019 DA - 2019// TI - Clinical intensity modulated proton therapy for Hodgkin lymphoma: which patients benefit the Most? JO - Pract Radiat Oncol VL - 9 UR - https://doi.org/10.1016/j.prro.2019.01.006 DO - 10.1016/j.prro.2019.01.006 ID - Ntentas2019 ER - TY - JOUR AU - Wray, J. AU - Flampouri, S. AU - Slayton, W. PY - 2016 DA - 2016// TI - Proton therapy for pediatric Hodgkin lymphoma JO - Pediatr Blood Cancer VL - 63 UR - https://doi.org/10.1002/pbc.26044 DO - 10.1002/pbc.26044 ID - Wray2016 ER - TY - STD TI - Mauz-Körholz C. Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents - EuroNet-PHL-C2. https://clinicaltrials.gov/ct2/show/NCT02684708. UR - https://clinicaltrials.gov/ct2/show/NCT02684708 ID - ref45 ER - TY - JOUR AU - Levis, M. AU - Filippi, A. R. AU - Fiandra, C. PY - 2019 DA - 2019// TI - Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients JO - Radiother Oncol VL - 138 UR - https://doi.org/10.1016/j.radonc.2019.05.009 DO - 10.1016/j.radonc.2019.05.009 ID - Levis2019 ER - TY - JOUR AU - Fiandra, C. AU - Filippi, A. R. AU - Catuzzo, P. PY - 2012 DA - 2012// TI - Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations JO - Radiat Oncol VL - 7 UR - https://doi.org/10.1186/1748-717X-7-186 DO - 10.1186/1748-717X-7-186 ID - Fiandra2012 ER - TY - JOUR AU - Flatten, V. AU - Baumann, K. -. S. AU - Weber, U. AU - Engenhart-Cabillic, R. AU - Zink, K. PY - 2019 DA - 2019// TI - Quantification of the dependencies of the Bragg peak degradation due to lung tissue in proton therapy on a CT-based lung tumor phantom JO - Phys Med Biol VL - 64 UR - https://doi.org/10.1088/1361-6560/ab2611 DO - 10.1088/1361-6560/ab2611 ID - Flatten2019 ER - TY - JOUR AU - Zenklusen, S. M. AU - Pedroni, E. AU - Meer, D. PY - 2010 DA - 2010// TI - A study on repainting strategies for treating moderately moving targets with proton pencil beam scanning at the new gantry 2 at PSI JO - Phys Med Biol VL - 55 UR - https://doi.org/10.1088/0031-9155/55/17/014 DO - 10.1088/0031-9155/55/17/014 ID - Zenklusen2010 ER - TY - JOUR AU - Fedorov, A. AU - Beichel, R. AU - Kalpathy-Cramer, J. PY - 2012 DA - 2012// TI - 3D slicer as an image computing platform for the quantitative imaging network JO - Magn Reson Imaging VL - 30 UR - https://doi.org/10.1016/j.mri.2012.05.001 DO - 10.1016/j.mri.2012.05.001 ID - Fedorov2012 ER - TY - JOUR AU - Grégoire, V. AU - Mackie, T. R. PY - 2011 DA - 2011// TI - State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83) JO - Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique VL - 15 UR - https://doi.org/10.1016/j.canrad.2011.04.003 DO - 10.1016/j.canrad.2011.04.003 ID - Grégoire2011 ER - TY - JOUR AU - Nimwegen, F. A. AU - Schaapveld, M. AU - Cutter, D. J. PY - 2016 DA - 2016// TI - Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.63.4444 DO - 10.1200/JCO.2015.63.4444 ID - Nimwegen2016 ER - TY - JOUR AU - Darby, S. C. AU - Ewertz, M. AU - McGale, P. PY - 2013 DA - 2013// TI - Risk of ischemic heart disease in women after radiotherapy for breast cancer JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1209825 DO - 10.1056/NEJMoa1209825 ID - Darby2013 ER - TY - JOUR AU - Maraldo, M. V. AU - Giusti, F. AU - Vogelius, I. R. PY - 2015 DA - 2015// TI - Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials JO - Lancet Haematol VL - 2 UR - https://doi.org/10.1016/S2352-3026(15)00153-2 DO - 10.1016/S2352-3026(15)00153-2 ID - Maraldo2015 ER - TY - STD TI - Cutter DJ, Schaapveld M, Darby SC, et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst. 2015;107. https://doi.org/10.1093/jnci/djv008. ID - ref55 ER - TY - JOUR AU - Constine, L. S. AU - Donaldson, S. S. AU - McDougall, I. R. AU - Cox, R. S. AU - Link, M. P. AU - Kaplan, H. S. PY - 1984 DA - 1984// TI - Thyroid dysfunction after radiotherapy in children with Hodgkin's disease JO - Cancer VL - 53 UR - https://doi.org/3.0.CO;2-J DO - 3.0.CO;2-J ID - Constine1984 ER - TY - JOUR AU - Cella, L. AU - Conson, M. AU - Caterino, M. PY - 2012 DA - 2012// TI - Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma JO - Int J Radiat Oncol Biol Phys VL - 82 UR - https://doi.org/10.1016/j.ijrobp.2010.09.054 DO - 10.1016/j.ijrobp.2010.09.054 ID - Cella2012 ER - TY - JOUR AU - Inskip, P. D. AU - Robison, L. L. AU - Stovall, M. PY - 2009 DA - 2009// TI - Radiation dose and breast cancer risk in the childhood cancer survivor study JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.7738 DO - 10.1200/JCO.2008.20.7738 ID - Inskip2009 ER - TY - JOUR AU - Hancock, S. L. AU - Tucker, M. A. AU - Hoppe, R. T. PY - 1993 DA - 1993// TI - Breast Cancer after treatment of Hodgkin's disease JO - JNCI Journal of the National Cancer Institute VL - 85 UR - https://doi.org/10.1093/jnci/85.1.25 DO - 10.1093/jnci/85.1.25 ID - Hancock1993 ER - TY - JOUR AU - Inskip, P. D. AU - Sigurdson, A. J. AU - Veiga, L. PY - 2016 DA - 2016// TI - Radiation-related new primary solid cancers in the childhood Cancer survivor study: comparative radiation dose response and modification of treatment effects JO - Int J Radiat Oncol Biol Phys VL - 94 UR - https://doi.org/10.1016/j.ijrobp.2015.11.046 DO - 10.1016/j.ijrobp.2015.11.046 ID - Inskip2016 ER - TY - JOUR AU - Schellong, G. AU - Riepenhausen, M. AU - Ehlert, K. PY - 2014 DA - 2014// TI - Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-up JO - Deutsches Arzteblatt international VL - 111 UR - https://doi.org/10.3238/arztebl.2014.0003 DO - 10.3238/arztebl.2014.0003 ID - Schellong2014 ER - TY - JOUR AU - Moskowitz, C. S. AU - Chou, J. F. AU - Wolden, S. L. PY - 2014 DA - 2014// TI - Breast cancer after chest radiation therapy for childhood cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.4601 DO - 10.1200/JCO.2013.54.4601 ID - Moskowitz2014 ER - TY - JOUR AU - Swerdlow, A. J. AU - Schoemaker, M. J. AU - Allerton, R. PY - 2001 DA - 2001// TI - Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment JO - J Clin Oncol VL - 19 UR - https://doi.org/10.1200/JCO.2001.19.6.1610 DO - 10.1200/JCO.2001.19.6.1610 ID - Swerdlow2001 ER - TY - JOUR AU - Inskip, P. D. AU - Stovall, M. AU - Flannery, J. T. PY - 1994 DA - 1994// TI - Lung Cancer risk and radiation dose among women treated for breast Cancer JO - J Natl Cancer Inst VL - 86 UR - https://doi.org/10.1093/jnci/86.13.983 DO - 10.1093/jnci/86.13.983 ID - Inskip1994 ER - TY - JOUR AU - Ron, E. AU - Lubin, J. H. AU - Shore, R. E. PY - 1995 DA - 1995// TI - Thyroid Cancer after exposure to external radiation: a pooled analysis of seven studies JO - Radiat Res VL - 141 UR - https://doi.org/10.2307/3579003 DO - 10.2307/3579003 ID - Ron1995 ER - TY - JOUR AU - Nimwegen, F. A. AU - Ntentas, G. AU - Darby, S. C. PY - 2017 DA - 2017// TI - Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines JO - Blood VL - 129 UR - https://doi.org/10.1182/blood-2016-09-740332 DO - 10.1182/blood-2016-09-740332 ID - Nimwegen2017 ER - TY - JOUR AU - Bovelli, D. AU - Plataniotis, G. AU - Roila, F. PY - 2010 DA - 2010// TI - Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO clinical practice guidelines JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq200 DO - 10.1093/annonc/mdq200 ID - Bovelli2010 ER - TY - JOUR AU - Avilés, A. AU - Neri, N. AU - Nambo, J. M. AU - Huerta-Guzman, J. AU - Talavera, A. AU - Cleto, S. PY - 2005 DA - 2005// TI - Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy JO - Leuk Lymphoma VL - 46 UR - https://doi.org/10.1080/10428190500063229 DO - 10.1080/10428190500063229 ID - Avilés2005 ER - TY - JOUR AU - Engert, A. AU - Haverkamp, H. AU - Kobe, C. PY - 2012 DA - 2012// TI - Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(11)61940-5 DO - 10.1016/S0140-6736(11)61940-5 ID - Engert2012 ER - TY - JOUR AU - Mudie, N. Y. AU - Swerdlow, A. J. AU - Higgins, C. D. PY - 2006 DA - 2006// TI - Risk of second malignancy after non-Hodgkin's lymphoma: a British cohort study JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.2200 DO - 10.1200/JCO.2005.04.2200 ID - Mudie2006 ER - TY - JOUR AU - Abou Yehia, Z. AU - Mikhaeel, G. N. AU - Smith, G. PY - 2016 DA - 2016// TI - Does bleomycin lung toxicity increase the risk of radiation pneumonitis in Hodgkin lymphoma? JO - Int J Radiat Oncol Biol Phys VL - 96 UR - https://doi.org/10.1016/j.ijrobp.2016.08.018 DO - 10.1016/j.ijrobp.2016.08.018 ID - Abou Yehia2016 ER - TY - JOUR AU - Dabaja, B. S. AU - Hoppe, B. S. AU - Plastaras, J. P. PY - 2018 DA - 2018// TI - Proton therapy for adults with mediastinal lymphomas: the international lymphoma radiation oncology group guidelines JO - Blood VL - 132 UR - https://doi.org/10.1182/blood-2018-03-837633 DO - 10.1182/blood-2018-03-837633 ID - Dabaja2018 ER -